Cellectar Receives New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dfd14724-19a7-4c6f-9acd-8321780ad489&Preview=1 -
Date
3/31/2010 -
Company Name
Cellectar -
Mailing Address
3301 Agriculte Drive Madison, WI 53716 -
Company Description
Capitalizing on the unique characteristics of malignant cancer cells, Cellectar’s molecules are designed to find, treat and follow malignancies through the delivery of radiopharmaceuticals in a novel, highly selective way. -
Website
http://www.cellectar.com -
Transaction Type
Venture Equity -
Transaction Amount
Undisclosed -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Advantage Capital Partners
